Copyright Reports & Markets. All rights reserved.

Global Liposome Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Liposome Service by Type
    • 1.3.1 Overview: Global Liposome Service Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Liposome Service Consumption Value Market Share by Type in 2025
    • 1.3.3 Liposome Development Services
    • 1.3.4 Liposome Customization Service
    • 1.3.5 Liposome Encapsulation Services
    • 1.3.6 Others
  • 1.4 Global Liposome Service Market by Application
    • 1.4.1 Overview: Global Liposome Service Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Pharmaceutical
    • 1.4.3 Life Sciences
    • 1.4.4 Cosmetics and Skin Care Industrial
    • 1.4.5 Others
  • 1.5 Global Liposome Service Market Size & Forecast
  • 1.6 Global Liposome Service Market Size and Forecast by Region
    • 1.6.1 Global Liposome Service Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Liposome Service Market Size by Region, (2021-2032)
    • 1.6.3 North America Liposome Service Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Liposome Service Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Liposome Service Market Size and Prospect (2021-2032)
    • 1.6.6 South America Liposome Service Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Liposome Service Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Acuitas Therapeutics
    • 2.1.1 Acuitas Therapeutics Details
    • 2.1.2 Acuitas Therapeutics Major Business
    • 2.1.3 Acuitas Therapeutics Liposome Service Product and Solutions
    • 2.1.4 Acuitas Therapeutics Liposome Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Acuitas Therapeutics Recent Developments and Future Plans
  • 2.2 CD Bioparticles
    • 2.2.1 CD Bioparticles Details
    • 2.2.2 CD Bioparticles Major Business
    • 2.2.3 CD Bioparticles Liposome Service Product and Solutions
    • 2.2.4 CD Bioparticles Liposome Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 CD Bioparticles Recent Developments and Future Plans
  • 2.3 Corden Pharma
    • 2.3.1 Corden Pharma Details
    • 2.3.2 Corden Pharma Major Business
    • 2.3.3 Corden Pharma Liposome Service Product and Solutions
    • 2.3.4 Corden Pharma Liposome Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Corden Pharma Recent Developments and Future Plans
  • 2.4 Creative Biolabs
    • 2.4.1 Creative Biolabs Details
    • 2.4.2 Creative Biolabs Major Business
    • 2.4.3 Creative Biolabs Liposome Service Product and Solutions
    • 2.4.4 Creative Biolabs Liposome Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Creative Biolabs Recent Developments and Future Plans
  • 2.5 Creative Biostruct
    • 2.5.1 Creative Biostruct Details
    • 2.5.2 Creative Biostruct Major Business
    • 2.5.3 Creative Biostruct Liposome Service Product and Solutions
    • 2.5.4 Creative Biostruct Liposome Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Creative Biostruct Recent Developments and Future Plans
  • 2.6 Encapsula NanoSciences
    • 2.6.1 Encapsula NanoSciences Details
    • 2.6.2 Encapsula NanoSciences Major Business
    • 2.6.3 Encapsula NanoSciences Liposome Service Product and Solutions
    • 2.6.4 Encapsula NanoSciences Liposome Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Encapsula NanoSciences Recent Developments and Future Plans
  • 2.7 Evonik
    • 2.7.1 Evonik Details
    • 2.7.2 Evonik Major Business
    • 2.7.3 Evonik Liposome Service Product and Solutions
    • 2.7.4 Evonik Liposome Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Evonik Recent Developments and Future Plans
  • 2.8 Exelead
    • 2.8.1 Exelead Details
    • 2.8.2 Exelead Major Business
    • 2.8.3 Exelead Liposome Service Product and Solutions
    • 2.8.4 Exelead Liposome Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Exelead Recent Developments and Future Plans
  • 2.9 FormuMax Scientific
    • 2.9.1 FormuMax Scientific Details
    • 2.9.2 FormuMax Scientific Major Business
    • 2.9.3 FormuMax Scientific Liposome Service Product and Solutions
    • 2.9.4 FormuMax Scientific Liposome Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 FormuMax Scientific Recent Developments and Future Plans
  • 2.10 FUJIFILM Pharmaceuticals USA
    • 2.10.1 FUJIFILM Pharmaceuticals USA Details
    • 2.10.2 FUJIFILM Pharmaceuticals USA Major Business
    • 2.10.3 FUJIFILM Pharmaceuticals USA Liposome Service Product and Solutions
    • 2.10.4 FUJIFILM Pharmaceuticals USA Liposome Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 FUJIFILM Pharmaceuticals USA Recent Developments and Future Plans
  • 2.11 GMPriority Pharma
    • 2.11.1 GMPriority Pharma Details
    • 2.11.2 GMPriority Pharma Major Business
    • 2.11.3 GMPriority Pharma Liposome Service Product and Solutions
    • 2.11.4 GMPriority Pharma Liposome Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 GMPriority Pharma Recent Developments and Future Plans
  • 2.12 Lipoid
    • 2.12.1 Lipoid Details
    • 2.12.2 Lipoid Major Business
    • 2.12.3 Lipoid Liposome Service Product and Solutions
    • 2.12.4 Lipoid Liposome Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Lipoid Recent Developments and Future Plans
  • 2.13 LIPOSOMA
    • 2.13.1 LIPOSOMA Details
    • 2.13.2 LIPOSOMA Major Business
    • 2.13.3 LIPOSOMA Liposome Service Product and Solutions
    • 2.13.4 LIPOSOMA Liposome Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 LIPOSOMA Recent Developments and Future Plans
  • 2.14 Merck KGaA
    • 2.14.1 Merck KGaA Details
    • 2.14.2 Merck KGaA Major Business
    • 2.14.3 Merck KGaA Liposome Service Product and Solutions
    • 2.14.4 Merck KGaA Liposome Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Merck KGaA Recent Developments and Future Plans
  • 2.15 Nippon Fine Chemical
    • 2.15.1 Nippon Fine Chemical Details
    • 2.15.2 Nippon Fine Chemical Major Business
    • 2.15.3 Nippon Fine Chemical Liposome Service Product and Solutions
    • 2.15.4 Nippon Fine Chemical Liposome Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Nippon Fine Chemical Recent Developments and Future Plans
  • 2.16 PlantaCorp
    • 2.16.1 PlantaCorp Details
    • 2.16.2 PlantaCorp Major Business
    • 2.16.3 PlantaCorp Liposome Service Product and Solutions
    • 2.16.4 PlantaCorp Liposome Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 PlantaCorp Recent Developments and Future Plans
  • 2.17 Polymun
    • 2.17.1 Polymun Details
    • 2.17.2 Polymun Major Business
    • 2.17.3 Polymun Liposome Service Product and Solutions
    • 2.17.4 Polymun Liposome Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Polymun Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Liposome Service Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Liposome Service by Company Revenue
    • 3.2.2 Top 3 Liposome Service Players Market Share in 2025
    • 3.2.3 Top 6 Liposome Service Players Market Share in 2025
  • 3.3 Liposome Service Market: Overall Company Footprint Analysis
    • 3.3.1 Liposome Service Market: Region Footprint
    • 3.3.2 Liposome Service Market: Company Product Type Footprint
    • 3.3.3 Liposome Service Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Liposome Service Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Liposome Service Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Liposome Service Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Liposome Service Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Liposome Service Consumption Value by Type (2021-2032)
  • 6.2 North America Liposome Service Market Size by Application (2021-2032)
  • 6.3 North America Liposome Service Market Size by Country
    • 6.3.1 North America Liposome Service Consumption Value by Country (2021-2032)
    • 6.3.2 United States Liposome Service Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Liposome Service Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Liposome Service Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Liposome Service Consumption Value by Type (2021-2032)
  • 7.2 Europe Liposome Service Consumption Value by Application (2021-2032)
  • 7.3 Europe Liposome Service Market Size by Country
    • 7.3.1 Europe Liposome Service Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Liposome Service Market Size and Forecast (2021-2032)
    • 7.3.3 France Liposome Service Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Liposome Service Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Liposome Service Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Liposome Service Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Liposome Service Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Liposome Service Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Liposome Service Market Size by Region
    • 8.3.1 Asia-Pacific Liposome Service Consumption Value by Region (2021-2032)
    • 8.3.2 China Liposome Service Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Liposome Service Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Liposome Service Market Size and Forecast (2021-2032)
    • 8.3.5 India Liposome Service Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Liposome Service Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Liposome Service Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Liposome Service Consumption Value by Type (2021-2032)
  • 9.2 South America Liposome Service Consumption Value by Application (2021-2032)
  • 9.3 South America Liposome Service Market Size by Country
    • 9.3.1 South America Liposome Service Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Liposome Service Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Liposome Service Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Liposome Service Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Liposome Service Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Liposome Service Market Size by Country
    • 10.3.1 Middle East & Africa Liposome Service Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Liposome Service Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Liposome Service Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Liposome Service Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Liposome Service Market Drivers
  • 11.2 Liposome Service Market Restraints
  • 11.3 Liposome Service Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Liposome Service Industry Chain
  • 12.2 Liposome Service Upstream Analysis
  • 12.3 Liposome Service Midstream Analysis
  • 12.4 Liposome Service Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Liposome Service market size was valued at US$ 1878 million in 2025 and is forecast to a readjusted size of US$ 2562 million by 2032 with a CAGR of 4.6% during review period.
    Liposome services mainly refer to the preparation, optimization and encapsulation of liposomes to provide delivery and packaging services for drugs, genes, vaccines and other substances.
    Since each application scenario may require different liposomes, being able to provide highly customized liposome services will be an important trend in the future.
    This report is a detailed and comprehensive analysis for global Liposome Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Liposome Service market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Liposome Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Liposome Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Liposome Service market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Liposome Service
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Liposome Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Acuitas Therapeutics, CD Bioparticles, Corden Pharma, Creative Biolabs, Creative Biostruct, Encapsula NanoSciences, Evonik, Exelead, FormuMax Scientific, FUJIFILM Pharmaceuticals USA, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Liposome Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Liposome Development Services
    Liposome Customization Service
    Liposome Encapsulation Services
    Others
    Market segment by Application
    Pharmaceutical
    Life Sciences
    Cosmetics and Skin Care Industrial
    Others
    Market segment by players, this report covers
    Acuitas Therapeutics
    CD Bioparticles
    Corden Pharma
    Creative Biolabs
    Creative Biostruct
    Encapsula NanoSciences
    Evonik
    Exelead
    FormuMax Scientific
    FUJIFILM Pharmaceuticals USA
    GMPriority Pharma
    Lipoid
    LIPOSOMA
    Merck KGaA
    Nippon Fine Chemical
    PlantaCorp
    Polymun
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Liposome Service product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Liposome Service, with revenue, gross margin, and global market share of Liposome Service from 2021 to 2026.
    Chapter 3, the Liposome Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Liposome Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Liposome Service.
    Chapter 13, to describe Liposome Service research findings and conclusion.

    Buy now